Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph Apr 8, 2008
April 7, 2008 /PRNewswire-FirstCall/ -- Genaera Corporation (Nasdaq: ) today announced, in compliance with NASDAQ Marketplace Rule 4350(b)(1)(B), that the audit report included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2007 contained an unqualified audit opinion from its independent registered public accounting firm, KPMG LLP, which included a "going concern" explanatory paragraph ... About Genaera Genaera Corporation is focused on advancing the science... (PR Newswire)
Genaera Corporation to Present at ThinkEquity Partners LLC Second ... Jul 31, 2007
Genaera Corporation to Present at ThinkEquity Partners LLC Second Annual ThinkBIG Conference ... Genaera Corporation to Present at ThinkEquity Partners LLC Second Annual ThinkBIG Conference ... July 30 /PRNewswire-FirstCall/ -- Genaera Corporation today announced that it will present at the ThinkEquity Partners LLC Second Annual ThinkBIG Conference at the Mandarin Oriental Hotel in New York City. (CNNMoney.com)
Macrochem acquires option to license pexiganan Jul 11, 2007
July 10 /PRNewswire-FirstCall/ -- MacroChem Corporation (OTCBB: MACM - News) today announced that it has signed an exclusive option to acquire exclusive worldwide license rights for drug uses of pexiganan, a novel, small peptide anti-infective for topical treatment of patients with mild diabetic foot infection (DFI), from Genaera Corporation (Genaera). "We believe this is a unique opportunity for MacroChem to broaden its product portfolio with a product that has already completed two Phase 3... (EurekAlert! -- Business News)
Genaera Corporation Announces 2006 Financial Results Mar 15, 2007
March 14 /PRNewswire-FirstCall/ -- Genaera Corporation (Nasdaq: ) today announced its financial results for the year and quarter ended December 31, 2006 ... "We accomplished many of the goals during 2006 that we set in the beginning of the year," stated Jack Armstrong, President and Chief Executive Officer of Genaera Corporation ... "While some of the decisions we made were more difficult than others, we look forward to capitalizing on the opportunities before us and unlocking the unrecognized... (PR Newswire)
Natural antibiotics yield secrets to atom-level imaging technique Mar 4, 2007
The work is highly interdisciplinary, involving not only Ramamoorthy's lab and several other groups in the Chemistry Department, but also researchers from the College of Engineering, the School of Dentistry, the Medical School and the Biophysics Research Division, as well as collaborators in Canada, Japan, India and the U.S. pharmaceutical companies Genaera Corporation and Eli Lilly and Company. Ramamoorthy was awarded support from the National Institutes of Health and the National Science... (EurekAlert!)
